List of Tables
Table 1. Global Multivalent Influenza Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Multivalent Influenza Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Multivalent Influenza Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Multivalent Influenza Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Multivalent Influenza Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Multivalent Influenza Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Multivalent Influenza Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Multivalent Influenza Vaccines Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Multivalent Influenza Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Multivalent Influenza Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Multivalent Influenza Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Multivalent Influenza Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Multivalent Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multivalent Influenza Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Multivalent Influenza Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Multivalent Influenza Vaccines Sales by Region (2020-2025) & (K Units)
Table 18. Global Multivalent Influenza Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global Multivalent Influenza Vaccines Sales by Region (2026-2031) & (K Units)
Table 20. Global Multivalent Influenza Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global Multivalent Influenza Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Multivalent Influenza Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global Multivalent Influenza Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Multivalent Influenza Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America Multivalent Influenza Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Multivalent Influenza Vaccines Sales by Country (2020-2025) & (K Units)
Table 27. North America Multivalent Influenza Vaccines Sales by Country (2026-2031) & (K Units)
Table 28. North America Multivalent Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Multivalent Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Multivalent Influenza Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Multivalent Influenza Vaccines Sales by Country (2020-2025) & (K Units)
Table 32. Europe Multivalent Influenza Vaccines Sales by Country (2026-2031) & (K Units)
Table 33. Europe Multivalent Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Multivalent Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Multivalent Influenza Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Multivalent Influenza Vaccines Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Multivalent Influenza Vaccines Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Multivalent Influenza Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Multivalent Influenza Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Multivalent Influenza Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Multivalent Influenza Vaccines Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Multivalent Influenza Vaccines Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Multivalent Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Multivalent Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Multivalent Influenza Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Multivalent Influenza Vaccines Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Multivalent Influenza Vaccines Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Multivalent Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Multivalent Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Multivalent Influenza Vaccines Sales (K Units) by Type (2020-2025)
Table 51. Global Multivalent Influenza Vaccines Sales (K Units) by Type (2026-2031)
Table 52. Global Multivalent Influenza Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global Multivalent Influenza Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global Multivalent Influenza Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Multivalent Influenza Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Multivalent Influenza Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global Multivalent Influenza Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global Multivalent Influenza Vaccines Price (US$/Unit) by Type (2020-2025)
Table 59. Global Multivalent Influenza Vaccines Price (US$/Unit) by Type (2026-2031)
Table 60. Global Multivalent Influenza Vaccines Sales (K Units) by Application (2020-2025)
Table 61. Global Multivalent Influenza Vaccines Sales (K Units) by Application (2026-2031)
Table 62. Global Multivalent Influenza Vaccines Sales Market Share by Application (2020-2025)
Table 63. Global Multivalent Influenza Vaccines Sales Market Share by Application (2026-2031)
Table 64. Global Multivalent Influenza Vaccines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Multivalent Influenza Vaccines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Multivalent Influenza Vaccines Revenue Market Share by Application (2020-2025)
Table 67. Global Multivalent Influenza Vaccines Revenue Market Share by Application (2026-2031)
Table 68. Global Multivalent Influenza Vaccines Price (US$/Unit) by Application (2020-2025)
Table 69. Global Multivalent Influenza Vaccines Price (US$/Unit) by Application (2026-2031)
Table 70. Sanofi Company Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Multivalent Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Sanofi Multivalent Influenza Vaccines Product
Table 74. Sanofi Recent Developments/Updates
Table 75. CSL Company Information
Table 76. CSL Description and Business Overview
Table 77. CSL Multivalent Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. CSL Multivalent Influenza Vaccines Product
Table 79. CSL Recent Developments/Updates
Table 80. GSK Company Information
Table 81. GSK Description and Business Overview
Table 82. GSK Multivalent Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. GSK Multivalent Influenza Vaccines Product
Table 84. GSK Recent Developments/Updates
Table 85. Viatris Company Information
Table 86. Viatris Description and Business Overview
Table 87. Viatris Multivalent Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Viatris Multivalent Influenza Vaccines Product
Table 89. Viatris Recent Developments/Updates
Table 90. AstraZeneca Company Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Multivalent Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. AstraZeneca Multivalent Influenza Vaccines Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. Hualan Bio Company Information
Table 96. Hualan Bio Description and Business Overview
Table 97. Hualan Bio Multivalent Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Hualan Bio Multivalent Influenza Vaccines Product
Table 99. Hualan Bio Recent Developments/Updates
Table 100. Changchun Institute of Biological Company Information
Table 101. Changchun Institute of Biological Description and Business Overview
Table 102. Changchun Institute of Biological Multivalent Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Changchun Institute of Biological Multivalent Influenza Vaccines Product
Table 104. Changchun Institute of Biological Recent Developments/Updates
Table 105. Sinovac Company Information
Table 106. Sinovac Description and Business Overview
Table 107. Sinovac Multivalent Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Sinovac Multivalent Influenza Vaccines Product
Table 109. Sinovac Recent Developments/Updates
Table 110. Bcht Biotechnology Company Information
Table 111. Bcht Biotechnology Description and Business Overview
Table 112. Bcht Biotechnology Multivalent Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Bcht Biotechnology Multivalent Influenza Vaccines Product
Table 114. Bcht Biotechnology Recent Developments/Updates
Table 115. Jiangsu GDK Company Information
Table 116. Jiangsu GDK Description and Business Overview
Table 117. Jiangsu GDK Multivalent Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Jiangsu GDK Multivalent Influenza Vaccines Product
Table 119. Jiangsu GDK Recent Developments/Updates
Table 120. KM Biologics Company Information
Table 121. KM Biologics Description and Business Overview
Table 122. KM Biologics Multivalent Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. KM Biologics Multivalent Influenza Vaccines Product
Table 124. KM Biologics Recent Developments/Updates
Table 125. ADIMMUNE Corporation Company Information
Table 126. ADIMMUNE Corporation Description and Business Overview
Table 127. ADIMMUNE Corporation Multivalent Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. ADIMMUNE Corporation Multivalent Influenza Vaccines Product
Table 129. ADIMMUNE Corporation Recent Developments/Updates
Table 130. Aleph Biomedical Company Information
Table 131. Aleph Biomedical Description and Business Overview
Table 132. Aleph Biomedical Multivalent Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Aleph Biomedical Multivalent Influenza Vaccines Product
Table 134. Aleph Biomedical Recent Developments/Updates
Table 135. Shanghai Institute of Biological Products Company Information
Table 136. Shanghai Institute of Biological Products Description and Business Overview
Table 137. Shanghai Institute of Biological Products Multivalent Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Shanghai Institute of Biological Products Multivalent Influenza Vaccines Product
Table 139. Shanghai Institute of Biological Products Recent Developments/Updates
Table 140. Zhongyianke Biotech Company Information
Table 141. Zhongyianke Biotech Description and Business Overview
Table 142. Zhongyianke Biotech Multivalent Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Zhongyianke Biotech Multivalent Influenza Vaccines Product
Table 144. Zhongyianke Biotech Recent Developments/Updates
Table 145. Wuhan Institute of Biological Products Company Information
Table 146. Wuhan Institute of Biological Products Description and Business Overview
Table 147. Wuhan Institute of Biological Products Multivalent Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Wuhan Institute of Biological Products Multivalent Influenza Vaccines Product
Table 149. Wuhan Institute of Biological Products Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Multivalent Influenza Vaccines Distributors List
Table 153. Multivalent Influenza Vaccines Customers List
Table 154. Multivalent Influenza Vaccines Market Trends
Table 155. Multivalent Influenza Vaccines Market Drivers
Table 156. Multivalent Influenza Vaccines Market Challenges
Table 157. Multivalent Influenza Vaccines Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Multivalent Influenza Vaccines
Figure 2. Global Multivalent Influenza Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Multivalent Influenza Vaccines Market Share by Type: 2024 & 2031
Figure 4. Trivalent Inactivated Influenza Vaccine (IIV3) Product Picture
Figure 5. Trivalent Live Attenuated Vaccine (LAIV3) Product Picture
Figure 6. Quadrivalent Inactivated Influenza Vaccine (IIV4) Product Picture
Figure 7. Global Multivalent Influenza Vaccines Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Multivalent Influenza Vaccines Market Share by Application: 2024 & 2031
Figure 9. 6 Months to 3 Years
Figure 10. Above 3 Years
Figure 11. Global Multivalent Influenza Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Multivalent Influenza Vaccines Market Size (2020-2031) & (US$ Million)
Figure 13. Global Multivalent Influenza Vaccines Sales (2020-2031) & (K Units)
Figure 14. Global Multivalent Influenza Vaccines Average Price (US$/Unit) & (2020-2031)
Figure 15. Multivalent Influenza Vaccines Report Years Considered
Figure 16. Multivalent Influenza Vaccines Sales Share by Manufacturers in 2024
Figure 17. Global Multivalent Influenza Vaccines Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Multivalent Influenza Vaccines Players: Market Share by Revenue in Multivalent Influenza Vaccines in 2024
Figure 19. Multivalent Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Multivalent Influenza Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Multivalent Influenza Vaccines Sales Market Share by Country (2020-2031)
Figure 22. North America Multivalent Influenza Vaccines Revenue Market Share by Country (2020-2031)
Figure 23. United States Multivalent Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Multivalent Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Multivalent Influenza Vaccines Sales Market Share by Country (2020-2031)
Figure 26. Europe Multivalent Influenza Vaccines Revenue Market Share by Country (2020-2031)
Figure 27. Germany Multivalent Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Multivalent Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Multivalent Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Multivalent Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Multivalent Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Multivalent Influenza Vaccines Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Multivalent Influenza Vaccines Revenue Market Share by Region (2020-2031)
Figure 34. China Multivalent Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Multivalent Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Multivalent Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Multivalent Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Multivalent Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Multivalent Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Multivalent Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Multivalent Influenza Vaccines Sales Market Share by Country (2020-2031)
Figure 42. Latin America Multivalent Influenza Vaccines Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Multivalent Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Multivalent Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Multivalent Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Multivalent Influenza Vaccines Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Multivalent Influenza Vaccines Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Multivalent Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Multivalent Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Multivalent Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Multivalent Influenza Vaccines by Type (2020-2031)
Figure 52. Global Revenue Market Share of Multivalent Influenza Vaccines by Type (2020-2031)
Figure 53. Global Multivalent Influenza Vaccines Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Multivalent Influenza Vaccines by Application (2020-2031)
Figure 55. Global Revenue Market Share of Multivalent Influenza Vaccines by Application (2020-2031)
Figure 56. Global Multivalent Influenza Vaccines Price (US$/Unit) by Application (2020-2031)
Figure 57. Multivalent Influenza Vaccines Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
